# Stoke Therapeutics, Inc.: Form 8-K, filed Oct 6, 2025

- Company: [Stoke Therapeutics, Inc.](/companies/stok.md) (CIK 1623526)
- Form: 8-K
- Filed: 2025-10-06
- Accepted by EDGAR: Oct 6, 2025, 07:30 ET
- Period: 2025-10-05
- Accession: 0001193125-25-230925
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1623526/000119312525230925/d55930d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1623526/000119312525230925/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1623526/000119312525230925/d55930d8k.htm

Filed Oct 6, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-230925. Last ingested by Listed: Nov 14, 2026, 21:52 ET. No prices; not investment advice.
